PubMed COVID-19 Clinical Care

CONCLUSION: To encourage COVID-19 vaccination, it is essential to provide clear information on adverse effects, particularly for women and individuals with fewer prior vaccinations. Reducing the out-of-pocket cost of vaccination to 3,000 to 5,000 JPY

In 2009 and again in 2019, public health warnings were confirmed by the emergence, rapid widespread transmission, and lethality of novel influenza and coronaviruses. The world continues to suffer disease from these respiratory viruses. Two newly

This study presents a comprehensive framework for infectious disease monitoring using fractional differential equations, specifically developing the SEIQRDP (Susceptible, Exposed, Infected, Quarantined, Recovered, Deceased, Protected) model

No abstract

CONCLUSION: S. Typhi blood culture positivity declined sharply during the pandemic before TCV introduction. The subsequent rollout of TCV substantially reduced typhoid burden in vaccine-eligible children; however, rising cases among older, vaccine

No abstract

This retrospective study analyzed epidemiological features of infections by 13 common respiratory pathogens among children in Shenzhen, China, from January 2020 to February 2025. A total of 73,886 throat swabs from pediatric patients with suspected

CONCLUSIONS: The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict

No abstract

The COVID-19 pandemic caused by SARS-CoV-2 underscored the global need for rapid, efficient drug discovery platforms to combat emerging viral threats. Conventional antiviral screening methods are often time-consuming and low-throughput, making them